ERCP among Cirrhotics: What are the differences?
| Autor: | Mohamed I Radwan, Mariam S Zaghloul, Ibrahim Amer, Soha A Elhawari, Eslam M Elshenawy, Mohamed H Ahmed, Aya M Mahrous, Mohamed H Emara, Hassan E Elbatee |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Average risk Cirrhosis Computer Networks and Communications business.industry medicine.disease digestive system digestive system diseases Bleeding diathesis Child class surgical procedures operative Hardware and Architecture Intervention (counseling) medicine Coagulopathy Pancreatitis Intensive care medicine business Adverse effect Software |
| Zdroj: | Afro-Egyptian Journal of Infectious and Endemic Diseases. |
| ISSN: | 2090-7184 |
| Popis: | The endoscopic retrograde cholangio-pancreatography (ERCP) is considered a main therapeutic intervention in the management of biliary and pancreatic disorders. In the average risk populations it is associated with adverse events. The most common adverse event is post-ERCP pancreatitis. Patients with liver cirrhosis are increasingly seen in ERCP theaters with different indications for the ERCP. Because cirrhotic patients are prone to complications it is expected that they develop more adverse events when operated with ERCP. Bleeding diathesis is the most serious because of the underlying coagulopathy and thrombocytopenia that are commonly encountered among them in particular with advanced Child class. In this mini review we discussed how different is the ERCP among cirrhotics regarding the expected benefits and the reported risks and we showed our experience in dealing with this subgroup of patients. The art of managing cirrhotic patients with ERCP is a team work and not a one man show. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|